Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 8.08 |
| Open | 8.09 |
| Bid | 7.77 x 300 |
| Ask | 7.83 x 700 |
| Day's range | 7.77 - 8.17 |
| 52-week range | 7.53 - 15.70 |
| Volume | |
| Avg. volume | 4,537,498 |
| Market cap | 1.224B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
- Investor's Business Daily
Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.
- Simply Wall St.
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
Ironwood Pharmaceuticals ( NASDAQ:IRWD ) Full Year 2023 Results Key Financial Results Revenue: US$442.7m (up 7.8% from...
© 2024 Yahoo. All rights reserved.